|
Re: AACR 2018
|
3
|
Zenith Epigenetics
|
Mar 06, 2018 03:46AM
|
|
Re: Chinese Takeovers
|
4
|
Zenith Epigenetics
|
Mar 07, 2018 12:56PM
|
|
Re: Chinese Takeovers
|
3
|
Zenith Epigenetics
|
Mar 08, 2018 03:59AM
|
|
Re: Chinese Takeovers
|
2
|
Zenith Epigenetics
|
Mar 08, 2018 12:54PM
|
|
Re: Novartis' canakinumab (Ilaris)
|
6
|
Resverlogix Corp.
|
Mar 13, 2018 02:25PM
|
|
Re: TSX Review
|
4
|
Resverlogix Corp.
|
Mar 14, 2018 02:27AM
|
|
Re: BIO-Europe Presentation
|
3
|
Resverlogix Corp.
|
Mar 14, 2018 12:28PM
|
|
Re: There is a positive side to the news...
|
5
|
Resverlogix Corp.
|
Mar 19, 2018 11:49AM
|
|
Re: There is a positive side to the news...
|
5
|
Resverlogix Corp.
|
Mar 19, 2018 12:53PM
|
|
Re: time to add/3 vs 5 pt. MACE
|
2
|
Resverlogix Corp.
|
Mar 20, 2018 10:00PM
|
|
Re: time to add/3 vs 5 pt. MACE
|
1
|
Resverlogix Corp.
|
Mar 21, 2018 04:44AM
|
|
Re: AEGIS-II trial
|
6
|
Resverlogix Corp.
|
Mar 22, 2018 12:35PM
|
|
Re: AEGIS-II trial
|
2
|
Resverlogix Corp.
|
Mar 23, 2018 11:27PM
|
|
Re: Is the message really getting out there
|
9
|
Resverlogix Corp.
|
Mar 28, 2018 02:31PM
|
|
Re: Que sera sera....
|
4
|
Resverlogix Corp.
|
Mar 30, 2018 01:50PM
|
|
Re: Que sera sera....
|
2
|
Resverlogix Corp.
|
Mar 30, 2018 02:39PM
|
|
Re: Que sera sera....
|
4
|
Resverlogix Corp.
|
Mar 31, 2018 04:11AM
|
|
Re: Que sera sera....
|
2
|
Resverlogix Corp.
|
Mar 31, 2018 02:46PM
|
|
Re: Que sera sera....
|
3
|
Resverlogix Corp.
|
Apr 03, 2018 06:05AM
|
|
Re: ZEN-3694/Enzalutamid... vs. Enzalutamide alone?
|
3
|
Zenith Epigenetics
|
Apr 08, 2018 01:16PM
|
